Talarmin, J.-P. | IICIMED

Talarmin, J.-P.

Publications

P151

Mycoses 2016, 59, 296-303.

Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.

Tadec, L. | Talarmin, J.-P. | Gastinne, T. | Bretonnière, C. | Miegeville, M. | Le Pape, P. | Morio, F.

doi: 10.1111/myc.12470

P143

Exp. Clin. Transplant. 2016, 14, 96-99.

Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy.

Ville, S. | Talarmin, J.-P. | Gaultier-Lintia, A. | Bouquié, R. | Sagan, C. | Le Pape, P. | Giral, M. | Morio, F.

doi: 10.6002/ect.2014.0093

P102

Med. Mycol., 2012, 50(6), 594-600. 

Phaeohyphomycosis due to Alternaria infectoria: a single-center experience with utility of PCR for diagnosis and species identification.

Robert, T. | Talarmin, J.-P. | Leterrier, M. | Cassagnau, E. | Le Pape, P. | Danner-Boucher, I. | Malard, O. | Brocard, A. | Gay-Andrieu, F. | Miegeville, M. | Morio, F.

Autres publications scientifiques

PS28

J Antimicrob Chemother 2023, 78(12):2919-2925.

Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.

Hervochon, C. | Hennart, B. | Leroy, A.-G. | Corvec, S. | Boutoille, D. | Senneville, E. | Sotto, A. | Illes, G. | Chavanet, P. | Dubée, V. | Bleibtreu, A. | De Carné, M.-C. | Talarmin, J.-P. | Revest, M. | Castan, B. | Bellouard, R. | Dailly, E. | Allorge, D. | Dinh, A. | Le Turnier, P. | Grégoire, M.

https://doi.org/10.1093/jac/dkad331

Brevets

Thèse